Arcutis Biotherapeutics, a commercial-stage biopharmaceutical company specializing in immuno-dermatology, announced it will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. The presentation will include a fireside chat accessible via webcast on the company's website, with a replay available for 180 days. This event highlights Arcutis' ongoing efforts to innovate in treatments for immune-mediated skin diseases and showcases its growing portfolio of targeted therapies. Investors and interested parties can follow the presentation to gain insights into the company's progress and future plans.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Ethereum rose 3.17% to $1,923.53, outperforming Bitcoin's modest 0.18% gain to $64,588.87, signaling an early rotation toward large-cap altcoins. Despite this, overall market activity slowed, with declines in DeFi, stablecoin, and derivatives trading...
Gabriel Holding A/S has agreed to sell its European FurnMaster furniture manufacturing operations, including subsidiaries in Poland and Lithuania, to Leggett & Platt for an initial price of approximately EUR 9 million, with a possible additional paym...
A Gaza resident raised over £55,000 on GoFundMe to support his family but faced issues as the platform cannot pay directly to Gaza, forcing funds through intermediaries who failed to deliver the full amount. This highlights a broader problem in human...
Crypto investigator ZachXBT criticized all current hardware wallets as insecure and unreliable for signing transactions or storing significant funds. He highlighted Ledger as particularly problematic due to frequent updates that disrupt basic functio...
